U.S. market Open. Closes in 5 hours 54 minutes

RMD | ResMed Inc. Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for RMD we got that it has strong fundamentals where Valuation is considered to be fairly valued, Profitability is stunning wealthy, Growth is exceptionally good and Health is very strong.

Valuation (59%)

Company Industry
P/E Ratio (TTM) 32.26 53.00
PEG Ratio (TTM) 3.55 6.93
P/S Ratio (TTM) 7.47 12.87
P/B Ratio (TTM) 6.91 6.84
P/FCF Ratio (TTM) 26.63 70.81
Price to 5YR AVG Earnings Ratio 47.06 110.82
Price to 5YR AVG FCF Ratio 53.49 92.94

Profitability (85%)

Company Industry
ROA (TTM) 15.41% 7.28%
ROE (TTM) 23.22% 13.21%
Net Profit Margin (TTM) 23.15% 2.69%
ROIC 5YR AVG 24.10% 11.56%

Growth (87%)

4QTR AVG 3YR AVG 5YR AVG
EPS 10.76% 30.49% 23.90%
Revenue 6.50% 11.16% 12.49%
Net Income 10.72% 31.42% 24.63%
Cash Flow 6.52% 4.75% 42.76%

Health (74%)

Company Industry
Current Ratio (TTM) 2.92 3.23
Quick Ratio (TTM) 1.91 2.41
D/E Ratio (TTM) 0.16 0.58
Interest Coverage (TTM) -43.76 31.67
Piotroski F-Score 6 6
Altman Z-Score 13.21 23.73
LTL to 5YR AVG FCF 1.04 4.05
Shares Outstanding Growth 5YR AVG 0.54% 2.42%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙